EGFR-directed therapy in lung cancer:
This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon muta...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Cambridge
Cambridge University Press
2023
|
Schriftenreihe: | Cambridge elements
|
Schlagworte: | |
Online-Zugang: | DE-12 DE-634 DE-92 Volltext |
Zusammenfassung: | This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations |
Beschreibung: | Also issued in print: 2023. - Includes bibliographical references |
Beschreibung: | 1 Online-Ressource (35 Seiten) Illustrationen |
ISBN: | 9781009342285 |
DOI: | 10.1017/9781009342285 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV048827428 | ||
003 | DE-604 | ||
007 | cr|uuu---uuuuu | ||
008 | 230223s2023 |||| o||u| ||||||eng d | ||
020 | |a 9781009342285 |c Online |9 978-1-00-934228-5 | ||
024 | 7 | |a 10.1017/9781009342285 |2 doi | |
035 | |a (ZDB-20-CBO)CR9781009342285 | ||
035 | |a (OCoLC)1371319845 | ||
035 | |a (DE-599)BVBBV048827428 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-92 |a DE-634 | ||
082 | 0 | |a 616.994240695 | |
084 | |a XH 5765 |0 (DE-625)152918:13144 |2 rvk | ||
100 | 1 | |a Kim, So Yeon |d ca. 20./21. Jh. |0 (DE-588)1281749796 |4 aut | |
245 | 1 | 0 | |a EGFR-directed therapy in lung cancer |c So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi, Balazs Halmos |
264 | 1 | |a Cambridge |b Cambridge University Press |c 2023 | |
300 | |a 1 Online-Ressource (35 Seiten) |b Illustrationen | ||
336 | |b txt |2 rdacontent | ||
336 | |b sti |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Cambridge elements | |
500 | |a Also issued in print: 2023. - Includes bibliographical references | ||
520 | |a This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations | ||
650 | 4 | |a Lungs / Cancer / Treatment | |
650 | 4 | |a Lungs / Cancer / Immunotherapy | |
650 | 4 | |a Gene therapy | |
700 | 1 | |a Costa, Daniel B. |d ca. 20./21. Jh. |0 (DE-588)1281750212 |4 aut | |
700 | 1 | |a Shibahara, Daisuke |d ca. 20./21. Jh. |0 (DE-588)1281751170 |4 aut | |
700 | 1 | |a Kobayashi, Susumu |d ca. 20./21. Jh. |0 (DE-588)1281751944 |4 aut | |
700 | 1 | |a Halmos, Balazs |d ca. 20./21. Jh. |0 (DE-588)1281752630 |4 aut | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-00-934230-8 |
856 | 4 | 0 | |u https://doi.org/10.1017/9781009342285 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-20-CBO | ||
966 | e | |u https://doi.org/10.1017/9781009342285 |l DE-12 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1017/9781009342285 |l DE-634 |p ZDB-20-CBO |q BTU_PDA_CBO |x Verlag |3 Volltext | |
966 | e | |u https://doi.org/10.1017/9781009342285 |l DE-92 |p ZDB-20-CBO |q FHN_PDA_CBO |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1805069254874103808 |
---|---|
adam_text | |
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Kim, So Yeon ca. 20./21. Jh Costa, Daniel B. ca. 20./21. Jh Shibahara, Daisuke ca. 20./21. Jh Kobayashi, Susumu ca. 20./21. Jh Halmos, Balazs ca. 20./21. Jh |
author_GND | (DE-588)1281749796 (DE-588)1281750212 (DE-588)1281751170 (DE-588)1281751944 (DE-588)1281752630 |
author_facet | Kim, So Yeon ca. 20./21. Jh Costa, Daniel B. ca. 20./21. Jh Shibahara, Daisuke ca. 20./21. Jh Kobayashi, Susumu ca. 20./21. Jh Halmos, Balazs ca. 20./21. Jh |
author_role | aut aut aut aut aut |
author_sort | Kim, So Yeon ca. 20./21. Jh |
author_variant | s y k sy syk d b c db dbc d s ds s k sk b h bh |
building | Verbundindex |
bvnumber | BV048827428 |
classification_rvk | XH 5765 |
collection | ZDB-20-CBO |
ctrlnum | (ZDB-20-CBO)CR9781009342285 (OCoLC)1371319845 (DE-599)BVBBV048827428 |
dewey-full | 616.994240695 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.994240695 |
dewey-search | 616.994240695 |
dewey-sort | 3616.994240695 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
discipline_str_mv | Medizin |
doi_str_mv | 10.1017/9781009342285 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a2200000zc 4500</leader><controlfield tag="001">BV048827428</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230223s2023 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009342285</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-00-934228-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/9781009342285</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781009342285</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1371319845</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048827428</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-634</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994240695</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 5765</subfield><subfield code="0">(DE-625)152918:13144</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kim, So Yeon</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="0">(DE-588)1281749796</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">EGFR-directed therapy in lung cancer</subfield><subfield code="c">So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi, Balazs Halmos</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (35 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">sti</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cambridge elements</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Also issued in print: 2023. - Includes bibliographical references</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lungs / Cancer / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lungs / Cancer / Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene therapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Costa, Daniel B.</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="0">(DE-588)1281750212</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shibahara, Daisuke</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="0">(DE-588)1281751170</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kobayashi, Susumu</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="0">(DE-588)1281751944</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Halmos, Balazs</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="0">(DE-588)1281752630</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-00-934230-8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/9781009342285</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009342285</subfield><subfield code="l">DE-12</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009342285</subfield><subfield code="l">DE-634</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BTU_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009342285</subfield><subfield code="l">DE-92</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">FHN_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV048827428 |
illustrated | Not Illustrated |
index_date | 2024-07-03T21:34:49Z |
indexdate | 2024-07-20T04:03:07Z |
institution | BVB |
isbn | 9781009342285 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034093045 |
oclc_num | 1371319845 |
open_access_boolean | |
owner | DE-12 DE-92 DE-634 |
owner_facet | DE-12 DE-92 DE-634 |
physical | 1 Online-Ressource (35 Seiten) Illustrationen |
psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO BTU_PDA_CBO ZDB-20-CBO FHN_PDA_CBO |
publishDate | 2023 |
publishDateSearch | 2023 |
publishDateSort | 2023 |
publisher | Cambridge University Press |
record_format | marc |
series2 | Cambridge elements |
spelling | Kim, So Yeon ca. 20./21. Jh. (DE-588)1281749796 aut EGFR-directed therapy in lung cancer So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi, Balazs Halmos Cambridge Cambridge University Press 2023 1 Online-Ressource (35 Seiten) Illustrationen txt rdacontent sti rdacontent c rdamedia cr rdacarrier Cambridge elements Also issued in print: 2023. - Includes bibliographical references This Element describes the structural biology and pathophysiology of EGFR-mutant NSCLC and describes past, current, and future treatment options in different settings. It discusses the biology and recently approved treatment for EGFR-exon 20 insertion mutation and the treatment for the uncommon mutations Lungs / Cancer / Treatment Lungs / Cancer / Immunotherapy Gene therapy Costa, Daniel B. ca. 20./21. Jh. (DE-588)1281750212 aut Shibahara, Daisuke ca. 20./21. Jh. (DE-588)1281751170 aut Kobayashi, Susumu ca. 20./21. Jh. (DE-588)1281751944 aut Halmos, Balazs ca. 20./21. Jh. (DE-588)1281752630 aut Erscheint auch als Druck-Ausgabe 978-1-00-934230-8 https://doi.org/10.1017/9781009342285 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Kim, So Yeon ca. 20./21. Jh Costa, Daniel B. ca. 20./21. Jh Shibahara, Daisuke ca. 20./21. Jh Kobayashi, Susumu ca. 20./21. Jh Halmos, Balazs ca. 20./21. Jh EGFR-directed therapy in lung cancer Lungs / Cancer / Treatment Lungs / Cancer / Immunotherapy Gene therapy |
title | EGFR-directed therapy in lung cancer |
title_auth | EGFR-directed therapy in lung cancer |
title_exact_search | EGFR-directed therapy in lung cancer |
title_exact_search_txtP | EGFR-directed therapy in lung cancer |
title_full | EGFR-directed therapy in lung cancer So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi, Balazs Halmos |
title_fullStr | EGFR-directed therapy in lung cancer So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi, Balazs Halmos |
title_full_unstemmed | EGFR-directed therapy in lung cancer So Yeon Kim, Daniel B. Costa, Daisuke Shibahara, Susumu Kobayashi, Balazs Halmos |
title_short | EGFR-directed therapy in lung cancer |
title_sort | egfr directed therapy in lung cancer |
topic | Lungs / Cancer / Treatment Lungs / Cancer / Immunotherapy Gene therapy |
topic_facet | Lungs / Cancer / Treatment Lungs / Cancer / Immunotherapy Gene therapy |
url | https://doi.org/10.1017/9781009342285 |
work_keys_str_mv | AT kimsoyeon egfrdirectedtherapyinlungcancer AT costadanielb egfrdirectedtherapyinlungcancer AT shibaharadaisuke egfrdirectedtherapyinlungcancer AT kobayashisusumu egfrdirectedtherapyinlungcancer AT halmosbalazs egfrdirectedtherapyinlungcancer |